PROM1 and breast carcinoma: In summary, we determined that CD133+ HPCs remarkably strengthened the malignancy of breast cancer cells by enhancing their proliferation and invasion, accompanied by attenuating spontaneous apoptosis in vitro and enhancing breast tumor growth in vivo.